INM vs LYFT · rev $4.9M vs P/E 108, rev $3.49B
InMed Pharmaceuticals Inc (INM) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported LYFT revenue for 2026-06-30 was $3.49B. Net income was $64.5M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
INM currently screens at market cap $5.2M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the INM and LYFT stock pages for the full models.
Not investment advice.